The Center for Cancer and Blood Disorders is represented in different locations in Texas, including Fort Worth – Central Campus, Fort Worth – Southwest, Arlington, Weatherford, Burleson, Cleburne, Granbury, Mineral Wells, and Stephenville.
All of the centers offer their patients cancer treatment options, such as chemotherapy, radiation therapy, immunotherapy, hormonal therapy, and biological therapy, as well as the opportunity to take advantage of innovative cancer treatment available only through clinical trials and cancer research.
At Fort Worth and other locations, patients and families can get involved in spiritual and emotional cancer support programs to help them to cope with the feelings that often come with cancer treatment. Relaxation therapy, pain management, massage therapy, and nutritional counseling are also provided.
Center for Cancer and Blood Disorders in Fort Worth
The Center for Cancer and Blood Disorders in Fort Worth is represented at two different locations in the city: the Central Campus and the Southwest.
The Fort Worth Central Campus is located in the medical district, on West Magnolia Avenue, and was designed to be a familiar location for practically all cancer treatment services. At this location, patients can find some of the finest technology in the United States gathered in the same place, which helps to eliminate some of the hassle often associated with complex medical care.
Located at Harris Southwest Hospital (in the John Ryan building), the Center for Cancer and Blood Disorders in Fort Worth’s Southwest offers its patients top-rated cancer care at an easily accessible location. A team of experienced medical oncologists evaluates and provides comprehensive cancer treatment options for patients, with the added reassurance of a familiar area and easy driving distance from the center.
Both Central Campus and Southwest locations are included in the Center for Cancer and Blood Disorders recent certification of outstanding quality of cancer treatment services, attributed only to 23 oncology practices in the US, by the Quality Oncology Practice Initiative Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO).
Clinical Trials at the Center for Cancer and Blood Disorders
Patients at the Center for Cancer and Blood Disorders may participate in a wide range of clinical trials for cancer research, to receive either a promising new cancer treatment or the best available conventional treatment. The advantage of being part of the trials lies in the possibility of being among the first patients to benefit if a new treatment option is proven to work. Though there are no assurances that any research will succeed, the Center for Cancer and Blood Disorders secures that clinical trials have been proven to offer some of the most effective cancer treatment currently available.
The Clinical Research Department is led by Dr. Ray Page, a cancer specialist in the area of medical oncology who has participated in research for more than 20 years and has published numerous papers. Besides Fort Worth (Central Campus and Southwest), the Center for Cancer & Blood Disorders also offers clinical trial participation to patients at Arlington, Burleson, Weatherford, Mineral Wells, Cleburne, Granbury, and Stephenville.
In order to develop the clinical trial options available to its patients, Center for Cancer and Blood Disorders has a partnership with Sarah Cannon Research Institute (SCRI), a global strategic research organization focusing on advancing therapies and accelerating drug development.